Home › NDC Lookup › Ingredients › Calcium Polycarbophil › 24385-0125-76
Good Neighbor Pharmacy Fiber-Caps Fiber Laxative Stimulant Free Calcium Polycarbophil 625 mg Capsule, 90-count — NDC 24385-0125-76 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Good Neighbor Pharmacy Fiber-Caps Fiber Laxative Stimulant Free Calcium Polycarbophil 625 mg Capsule, 90-count — NDC 24385-125-76 (Billing 24385-0125-76)

by Amerisourcebergen Drug Corporation · 90 CAPSULE in 1 BOTTLE

This is a package of 90 capsules of Good Neighbor Pharmacy Fiber-Caps Fiber Laxative Stimulant Free Calcium Polycarbophil 625 mg Capsule from Amerisourcebergen Drug Corporation, marketed since Jul 2010 and currently FDA-listed; retail pharmacies pay about $0.0591 per capsule (NADAC). It is the main listing for this product, which comes in 3 package sizes.

NDC 24385-0125-76
🏷️ FDA NDC (as labeled) 24385-125-76 billing pads the product segment with a zero
This package
Contains90-count Cost per ea$0.0591 NADAC Per package$5.32 / 90 capsules Pack sizes3 compare ↓
Also priced by: Medicaid pays $0.1457/unit — full pricing hub ↓
Main listing for product 24385-125 · Also comes in: 90 capsules 24385-125-27 90 capsules 24385-125-96
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 24385-125-76
Product NDC 24385-125
11-digit billing NDC 24385012576
NCPDP billing unit EA — each (per item)
UNII 8F049NKY49
Application # M007
SPL Set ID 4911fb44-e070-46c1-8f90-b78ceb10e51e
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2010-07-13
Route ORAL
Dosage form CAPSULE
Substance CALCIUM POLYCARBOPHIL

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 46300020100310
GPI class GNP Fiber-Caps
GCN Seq No 003065
GCN 08342
HICL code 001346
Ingredient (HICL) Calcium Polycarbophil
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Colon
HIC3 code D6S
Therapeutic class — specific (HIC3) Laxatives And Cathartics
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name FIBER TABS
FDB brand name Fiber Tabs
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 003065
  • GCN: 08342
  • GPI-14 (Medi-Span): 46300020100310
  • HICL (First Databank): 001346
  • AHFS class code: 56:12.00.00
Why two NDCs? The FDA registers this code as 24385-125-76 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 24385-0125-76. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name FIBER TABS Ingredient Calcium Polycarbophil
🧪 What is this product?

This is an oral capsule containing calcium polycarbophil, an over-the-counter laxative product sold under FDA's established monograph rules for this category. Calcium polycarbophil is typically used to relieve occasional constipation by absorbing water in the intestines and forming a larger stool mass that encourages bowel movement. The product is labeled as stimulant-free, meaning it works through a different mechanism than stimulant laxatives.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.059 $5.32 / 90 capsules
Medicaid paysCMS SDUD · 12 mo $0.1457 $13.11 / 90 capsules
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2021 Apr 2022 Aug 2022 Sep 2026 $0.065 $0.056
▲ Up 6% over the last 14 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
24385-0125-27 24385-125-27 90 CAPSULE in 1 BOTTLE, PLASTIC — — 2010-07-13 — Active
24385-0125-76 You're viewing this Main listing 90 CAPSULE in 1 BOTTLE $0.0591 / ea $5.32 2024-06-20 — Active
24385-0125-96 24385-125-96 90 CAPSULE in 1 BOTTLE, PLASTIC — — 2010-07-13 — Active

In Medicaid, this is the most-dispensed pack of this product — about 100% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This is a 90-count package — 90 capsule in 1 bottle.
How does this package differ from NDC 24385-0125-27?
Both are Good Neighbor Pharmacy Fiber-Caps Fiber Laxative Stimulant Free Calcium Polycarbophil 625 mg Capsule — the drug itself is identical. This page's package is the 90-count one, while NDC 24385-0125-27 is the 90 capsules package.
What NDC number is used to bill for this package of Good Neighbor Pharmacy Fiber-Caps Fiber Laxative Stimulant Free Calcium Polycarbophil 625 mg Capsule?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Fiber Lax 625 mg 00536-4306-05 Rugby 500 tablets $0.059 — Availability likely —
Fiber Tabs 625 mg 00904-2500-91 Major 90 tablets $0.059 — Availability likely —
Good Neighbor Pharmacy Fiber-Caps Fiber Laxative Stimulant Free 625 mgthis 24385-0125-76 Amerisourcebergen 90 capsules $0.059 — Availability likely —
Calcium Polycarbophil 625 mg 70000-0067-01 LEADER/ 250 tablets $0.059 — Availability likely —
Foster and Thrive Fiber Laxative 147 625 mg 70677-1083-01 Strategic 90 tablets $0.059 — Availability likely —
Fiber caplets 147 625 mg 83324-0131-90 Chain 90 tablets $0.059 — Availability likely —
Walgreen Fiber Lax 625 mg 00363-0120-14 WALGREENS 140 tablets — — FDA listed —
up and up fiber therapy 625 mg 11673-0620-90 Target 140 tablets — — FDA listed —
Rite Aid Fiber Caplets 625 mg 11822-2025-00 RITE 250 tablets — — FDA listed —
Fiber Caplets 625 mg 21130-0021-40 SAFEWAY 140 tablets — — FDA listed —
Fiber Caplets 625 mg 30142-0132-14 THE 140 tablets — — FDA listed —
Fiber Laxative 625 mg 36800-0465-27 Topco 90 tablets — — FDA listed —
Fiber Laxative 625 mg 41163-0147-94 UNITED 140 tablets — — FDA listed —
Publix 625 mg 41415-0021-90 PUBLIX 90 tablets — — FDA listed —
Fiber Therapy 625 mg 49035-0147-94 Wal-Mart 140 tablets — — FDA listed —
Goodsense Fiber laxative 147 625 mg 50804-0147-94 GoodSense 140 tablets — — FDA listed —
Fiber Caps 625 mg 53041-0147-27 Guardian 90 tablets — — FDA listed —
Fiber laxative 625 mg 53943-0147-27 Discount 90 tablets — — FDA listed —
Fiber Laxative 625 mg 54257-0379-07 Magno-Humphries, 90 tablets — — FDA listed —
Fiber Laxative 625 mg 54257-0479-07 Magno-Humphries, 90 tablets — — FDA listed —
Fiber Lax 625 mg 55289-0949-30 PD-Rx 30 tablets — — FDA listed —
Fiber Laxative 625 mg 57896-0459-09 Geri-Care 90 tablets — — FDA listed —
Calcium Polycarbophil 625 mg 58624-5003-01 SHANDONG 90 tablets — — FDA listed —
Quality Choice 625 mg 63868-0530-90 QUALITY 90 tablets — — FDA listed —
Best Choice 625 mg 63941-0023-90 BEST 90 tablets — — FDA listed —
Premier Value 625 mg 68016-0220-25 PHARMACY 250 tablets — — FDA listed —
Calcium Polycarbophil 625 mg 69842-0846-02 CVS 250 tablets — — FDA listed —
Calcium Polycarbophil 625 mg 70369-0006-08 CITRAGEN 120 tablets — — FDA listed —
Amazon Fiber Caplets 625 mg 72288-0201-40 AMAZON.COM 140 tablets — — FDA listed —
Fiber Laxative Caplets 625 mg 77333-0120-50 Gendose 50 tablets — — FDA listed —
Meijer Fiber Caplets 625 mg 79481-1205-00 MEIJER 250 tablets — — FDA listed —
Fibercon 625 mg 80070-0500-14 Foundation 140 tablets — — FDA listed —
Quality Choice Fiber Caplets 625 mg 83324-0276-14 QUALITY 140 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2010
On the market since
Jul 2010
📍
2026
Currently FDA-listed
16 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white
Shapecapsule
ImprintG147
Size18 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII H0G9379FGK
    Calcium carbonate is a white mineral powder used as a filler and buffering agent in medicines. It helps give tablets their bulk and size while neutralizing stomach acid in some formulations.
  • UNII T9D99G2B1R
    Caramel is a brown coloring substance made by heating sugar. It's added to medicines to give them color and sometimes a slight sweet taste without affecting how the drug works.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 2S7830E561
    Crospovidone is a synthetic polymer derived from povidone. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the active ingredient can be absorbed.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 3WJQ0SDW1A
    Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 368GB5141J
    A detergent and foaming agent derived from coconut or palm oil. In medications, it helps break down and mix oil and water-based ingredients, aids in tablet disintegration, and improves how the drug dissolves and spreads in the mouth or digestive system.

9 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescalcium carbonate,  caramel, colloidal silicon dioxide, crospovidone, hydroxypropyl  methylcellulose, magnesium stearate, microcrystalline cellulose,  polyethylene glycol, sodium lauryl sulfate.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAmerisourcebergen Drug Corporation
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code24385
First marketedJul 2010
Product typeHuman Otc Drug
Portfolio37 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 15 words ▾

Uses relieves: occasional constipation this product generally produces bowel movement in 12 to 72 hours

⏱️ Dosage and Administration 80 words ▾

Directions take this product (child or adult dose) with a full glass of water (8oz.) or other fluid. Taking this product without enough liquid may cause choking. See choking warning. dosage will vary according to diet, exercise, previous laxative use or severity of constipation continued use for 1 to 3 days is normally required to provide full benefit adults and children 12 years & over 2 caplets, 1 to 4 times a day children under 12 years ask a doctor

⚠️ Warnings 212 words ▾

Warnings Choking: Taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking. Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product, seek immediate medical attention.

Ask a doctor before use if you have abdominal pain, nausea or vomiting difficulty in swallowing a sudden change in bowel habits that persists over a period of 2 weeks Ask a doctor or pharmacist before use if you are taking any other drug. Take this product 2 or more hours before or after other drugs. All laxatives may affect how other drugs work.

When using this product do not use for more than 7 days unless directed by a doctor do not take more than 8 caplets in a 24 hour period unless directed by a doctor Stop use and ask a doctor if you experience chest pain, abdominal pain, nausea, vomiting, difficulty in breathing or swallowing you fail to have a bowel movement after use rectal bleeding occurs These could be signs of serious condition. Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center immediately.

📦 Storage and Handling 16 words ▾

Other information each caplet contains: calcium 135 mg store at room temperature protect contents from moisture

🧪 Active Ingredient 14 words ▾

Active ingredient (in each caplet) Calcium polycarbophil 625 mg equivalent to 500 mg polycarbophil

🧪 Inactive Ingredients 20 words ▾

Inactive ingredients calcium carbonate, caramel, colloidal silicon dioxide, crospovidone, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium lauryl sulfate.

🎯 Purpose 3 words ▾

Purpose Bulk-forming laxative

📄 Ask a Doctor Before Use If 30 words ▾

Ask a doctor before use if you have abdominal pain, nausea or vomiting difficulty in swallowing a sudden change in bowel habits that persists over a period of 2 weeks

📄 Ask a Doctor or Pharmacist Before Use If 34 words ▾

Ask a doctor or pharmacist before use if you are taking any other drug. Take this product 2 or more hours before or after other drugs. All laxatives may affect how other drugs work.

📄 When Using This Product 34 words ▾

When using this product do not use for more than 7 days unless directed by a doctor do not take more than 8 caplets in a 24 hour period unless directed by a doctor

📄 Stop Use and Ask a Doctor If 39 words ▾

Stop use and ask a doctor if you experience chest pain, abdominal pain, nausea, vomiting, difficulty in breathing or swallowing you fail to have a bowel movement after use rectal bleeding occurs These could be signs of serious condition.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center immediately.

📄 Package Label / Principal Display Panel 30 words ▾

principal display panel NDC 24385-125-76 Compare To Fibercon ® active ingredient* GOOD NEIGHBOR PHARMACY stimulant free Fiber-Caps Fiber Laxative relieves constipation helps restore & maintain regularity 90 caplets image description

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
483
Units reimbursed last 4 qtrs
33.4K
Gross reimbursed last 4 qtrs
$4.9K
Avg / prescription
$10.07
Avg / unit
$0.1457
Latest quarter Q1 2026
105Rx
Medicaid pays / ea
$0.1457
gross reimbursed
vs
NADAC / ea
$0.0591
acquisition cost
=
Spread
+$0.0866
+147% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
53% FFS 47% MCO
Fee-for-service · 254 Rx Managed care · 229 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 10,514 units · 183 per 100k residents MN Wisconsin: no data reported WI Michigan: no data reported MI New York: 16,920 units · 86.5 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: no data reported OH Pennsylvania: no data reported PA New Jersey: no data reported NJ Massachusetts: 2,674 units · 38.2 per 100k residents MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 750 units · 37.9 per 100k residents NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: 2,515 units · 28.9 per 100k residents VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
28.9183
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Minnesota 183 /100k
2 New York 86.5 /100k
3 Massachusetts 38.2 /100k
4 Nebraska 37.9 /100k
5 Virginia 28.9 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
90 capsules24385-0125-27 No Medicaid data
90 capsules24385-0125-96 No Medicaid data
Drug total (last 4 qtrs): 483 Rx · 33,373 units · $4,862 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.